Publicacións (12) Publicacións de Isaura Fernández Pérez

2023

  1. Immune checkpoint inhibitor-associated thrombosis in patients with bladder and kidney cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group

    Clinical and Translational Oncology, Vol. 25, Núm. 10, pp. 3021-3031

  2. Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme

    European Journal of Cancer, Vol. 182, pp. 3-14

2022

  1. Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial

    Thrombosis and haemostasis, Vol. 122, Núm. 10, pp. 1653-1661

  2. SEOM—GECOD clinical guideline for unknown primary cancer (2021)

    Clinical and Translational Oncology, Vol. 24, Núm. 4, pp. 681-692

  3. Utility of Genomic Platforms in Treatment Decisions in Axilla-Positive Breast Cancer

    Clinical Breast Cancer, Vol. 22, Núm. 7, pp. 634-641

2020

  1. A snapshot of cancer-associated thromboembolic disease in 2018–2019: First data from the TESEO prospective registry

    European Journal of Internal Medicine, Vol. 78, pp. 41-49

2017

  1. Breast cancer chemoprevention: What and when?

    Cancer and Chemotherapy Reviews, Vol. 12, Núm. 2, pp. 46-57

2015

  1. Trombosis venosa asociada a catéter venoso central en pacientes con cáncer

    Medicina Clinica, Vol. 144, Núm. S1, pp. 41-43

2011

  1. 1ª guía de cáncer hereditario: Galicia

    Sociedad Oncológica de Galicia

2007

  1. Disseminated classic Kaposi's sarcoma

    Clinical and Translational Oncology, Vol. 9, Núm. 4, pp. 255-257

  2. Gliomatosis cerebri: Diagnóstico y tratamiento con temozolomida, a propósito de un caso

    Oncologia, Vol. 30, Núm. 3, pp. 41-45

  3. Renal primary angiosarcoma

    Clinical and Translational Oncology, Vol. 9, Núm. 12, pp. 806-810